ArticleBone marrow transplantation2024

A novel approach to visualize clinical benefit of therapies for chronic graft versus host disease (cGvHD): the probability of being in response (PBR) applied to the REACH3 study.

Norbert Hollaender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.